Article
The A445C Variant in Apelin Receptor and Diabetic Retinopathy in Tunisian Patients.
Clinical laboratory - 1 Feb 2017
Soualmia Hayet, Midani Fatma, Hadj-Fradj Sondess, Saadi Nedra, Lassoued Mehdi, Messoud Taieb, Gharbi Monia, Ben-Amor Zohra
Abstract excerpt
BACKGROUND: Apelin and apelin receptor (APLN/APLNR) are involved in the retinal neovascularization of diabetic retinopathy (DR). METHODS: This study investigated the impact of the APLNR A445C variant on the risk of DR in a sample of the Tunisian population (100 patients with DR and 105 healthy controls) using PCR-RFLP. RESULTS: The genotype frequencies of the APLNR A445C variant were not significantly different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
